Innovita Biological Technology Co. Ltd. A (688253 SHG) stock market data APIs
Innovita Biological Technology Co. Ltd. A Financial Data Overview
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, focuses on the research and development, production and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; gastrointestinal virus testing; respiratory tract infections solutions; pregnancy test; hepatitis virus testing; and eugenics testing. The company was founded in 2006 and is based in Beijing, China.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Innovita Biological Technology Co. Ltd. A data using free add-ons & libraries
Get Innovita Biological Technology Co. Ltd. A Fundamental Data
Innovita Biological Technology Co. Ltd. A Fundamental data includes:
- Net Revenue: 547 M
- EBITDA: 199 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Innovita Biological Technology Co. Ltd. A Earnings data
What’s included:
- Latest Release: 2023-03-31
- EPS/Forecast: NaN
Get Innovita Biological Technology Co. Ltd. A End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
